Registry and biorepository for patients with inflammatory bowel diseases in Central Texas
Official title: Registry and Biorepository for the Study of Inflammatory Bowel Diseases in Central Texas
Run by University of Texas at Austin · NCT04617184 · Data updated 2026-11-12
This study is trying to create a database and collection of samples from people with inflammatory bowel diseases like Crohn's and ulcerative colitis to help future research on these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 1 site (Austin, Texas) |
| Status | Recruiting |
| Started | June 1, 2021 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | May 18, 2021 |
| Trial ID | NCT04617184 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with known or suspected inflammatory bowel disease who can provide informed consent.
✕Probably not a fit
Patients who are unable to comprehend or cooperate with study activities or those too ill to provide consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create a registry and biorepository for patients diagnosed with inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. It involves the prospective collection of clinical data and biological samples, including blood, tissue, and fecal samples, during routine medical procedures. Participants will provide consent to share their health information and samples, which will be used for future research on IBD. The study will follow patients longitudinally, gathering data from both the patients and their gastroenterologists.
Why it matters
Potential benefit: If successful, this study could enhance understanding of inflammatory bowel diseases and lead to improved treatment strategies.
How similar studies have gone: Other studies utilizing registries and biorepositories for chronic diseases have shown success in advancing research and treatment options.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, age 18 years or older * Willing and able to provide written consent for participation in the registry and biorepository * Patients with known or suspected inflammatory bowel disease Exclusion Criteria: * Patient is unable to comprehend and/or cooperate with study activities * Patient is too ill to provide consent * Coagulopathy that precludes safe biopsy of the bowel * Comorbidity that precludes safe participation in endoscopic procedures
Where it's running
-
Dell Medical School, UT Austin
Austin, Texas, United States Recruiting
Study contacts
- Study coordinator: Benjamin Chebaa, BA
- Email: benjamin.chebaa@austin.utexas.edu
- Phone: 5124955641
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Self-management program to improve health in inflammatory bowel disease
A digital self-management program is being tested to see if it helps people with inflammatory bowel disease feel better and manage their symptoms alongside standard care.
-
Observational study comparing inflammatory markers in IBD and non-IBD participants
This study is trying to see how inflammation levels in people with Crohn's Disease and Ulcerative Colitis compare to those without these conditions when they start new treatments.
-
Evaluating robotic surgery for inflammatory bowel disease
This study is testing if robotic surgery can be a good option for adults with inflammatory bowel disease, like Crohn's or ulcerative colitis, compared to traditional surgery methods.
-
How nutrition and body composition relate to outcomes in people with IBD
This study will see if nutrition and muscle mass affect outcomes in people with Crohn's disease or ulcerative colitis who are starting advanced medicines or having IBD-related surgery.
-
Research on gut inflammation in pediatric patients with inflammatory bowel diseases
This study is trying to learn more about gut inflammation in kids with inflammatory bowel diseases by collecting health information and samples from them and comparing it to kids who have different gut issues but no inflammation.
-
Switching to subcutaneous infliximab for IBD treatment
This study is testing if switching people with inflammatory bowel disease from an intravenous form of infliximab to a subcutaneous version, given weekly or bi-weekly, can lead to better health results.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.